Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma
Abstract Background Osteosarcoma is aggressive and prognostic biomarkers are important to predict the outcomes of surgery and chemotherapy. Here, we investigated the potential of transferrin receptor-1 (TfR1) and vascular endothelial growth factor (VEGF) as prognostic markers of osteosarcoma. Method...
Main Authors: | Hongzeng Wu, Jinming Zhang, Ruoheng Dai, Jianfa Xu, Helin Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-019-1301-z |
Similar Items
-
Expression of transferrin receptor‐1 (TFR‐1) in canine osteosarcomas
by: Gionata De Vico, et al.
Published: (2020-08-01) -
Role of Fe, Transferrin and Transferrin Receptor in Anti-Tumor Effect of Vitamin C
by: Jia Qiu, et al.
Published: (2022-09-01) -
Serum Soluble Transferrin Receptor and Transferrin Levels among Regular Blood Donors
by: Samuel K. Appiah, et al.
Published: (2022-09-01) -
The Trypanosomal Transferrin Receptor of Trypanosoma Brucei—A Review
by: Christopher K. Kariuki, et al.
Published: (2019-10-01) -
Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study
by: Henri Weidmann, et al.
Published: (2020-05-01)